Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Massarella
The Comparative Pharmacokinetics and Safety of the Oral Neuraminidase Inhibitor Oseltamivir When Given in Multiple Doses to Healthy Japanese and Caucasian Subjects.
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Related publications
Pharmacokinetics and Safety of Enasidenib Following Single Oral Doses in Japanese and Caucasian Subjects
Pharmacology Research and Perspectives
Toxicology
Neurology
Pharmaceutics
Pharmacology
Comparison of the Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Healthy Japanese and Caucasian Subjects
Clinical Drug Investigation
Medicine
Pharmacology
Pharmacokinetics, Pharmacodynamics, and Safety of Peficitinib (ASP015K) in Healthy Male Caucasian and Japanese Subjects
Clinical Drug Investigation
Medicine
Pharmacology
Erratum to : Efficacy and Safety of the Selective Oral Neuraminidase Inhibitor Oseltamivir for Prophylaxis Against Influenza
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Medicine
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Empagliflozin, a Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor, in Healthy Japanese Subjects
Drug Metabolism and Pharmacokinetics
Pharmacology
Pharmaceutical Science
Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Pharmacokinetics, Pharmacodynamics, Tolerability and Safety of Single Doses of Bivalirudin in Healthy Chinese Subjects
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Safety, Pharmacokinetics and Pharmacodynamics of Single Doses of Rivaroxaban – An Oral, Direct Factor Xa Inhibitor – In Elderly Chinese Subjects
Thrombosis and Haemostasis
Hematology
Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials
Journal of Clinical Pharmacology
Pharmacology
